SlideShare uma empresa Scribd logo
1 de 6
Baixar para ler offline
TOXICOLOGY/ORIGINAL RESEARCH


                 A Simple Quantitative Bedside Test to Determine
                                Methemoglobin
Fathima Shihana, BSc                  From the South Asian Clinical Toxicology Research Collaboration (Shihana, Dissanayake, Buckley,
Dhammika Menike                       Dawson) and Department of Pathology, Faculty of Medicine (Shihana, Dissanayake), University of
                                      Peradeniya, Peradeniya, Sri Lanka; The POW Clinical School, University of New South Wales,
  Dissanayake, MD, PhD
                                      Sydney, Australia (Buckley); and the School of Population Health, University of Newcastle,
Nicholas Allan Buckley, MD,           Newcastle, Australia (Dawson).
  FRACP
Andrew Hamilton Dawson,
  FRACP, FRCP


         Study objective: Methemoglobinemia after pesticide poisoning is associated with a mortality of 12% in Sri
         Lanka. Treatment is complicated by the lack of laboratory facilities. We aimed to develop and validate a low-cost
         bedside test for quantitative estimation of clinically significant methemoglobin to be used in settings of limited
         resources.

         Methods: A method to reliably produce blood samples with 10% to 100% methemoglobin was developed.
         Freshly prepared methemoglobin samples were used to develop the color chart. One drop (10 L) of
         prepared methemoglobin sample was placed on white absorbent paper and scanned using a flatbed Cannon
         Scan LiDE 25 scanner. The mean red, green, and blue values were measured with ImageJ 1.37v. These
         color values were used to prepare a color chart to be used at the bedside. Interobserver agreement was
         assessed against prepared samples. The results from clinical use were compared with formal
         methemoglobin measurements.

         Results: The red color value was linearly related to percentage methemoglobin (R2 0.9938), with no effect of
         absolute hemoglobin concentration. Mean interobserver (N 21) agreement and weighted for scanned
         methemoglobin spots using the color chart were 94% and 0.83, respectively. Mean interobserver (N 9)
         agreement and weighted for a freshly prepared methemoglobin sample with the chart were 88% and 0.71,
         respectively. Clinical use of the color chart also showed good agreement with spectrometric measurements.

         Conclusion: A color chart can be used to give a clinically useful quantitative estimate of methemoglobinemia.
         [Ann Emerg Med. 2010;55:184-189.]

         Please see page 185 for the Editor’s Capsule Summary of this article.


    Provide feedback on this article at the journal’s Web site, www.annemergmed.com.
0196-0644/$-see front matter
Copyright © 2009 by the American College of Emergency Physicians.
doi:10.1016/j.annemergmed.2009.07.022



INTRODUCTION                                                           recurrence is common and repeated dosing is required for some
    Methemoglobinemia can be a life-threatening complication           patients.8 However, doses of greater than 4 mg/kg methylene
after exposure to a range of chemicals such as nitrates, nitrites,     blue may actually exacerbate the methemoglobinemia, especially
and aniline and drugs such as dapsone.1-4 Antidote treatment           in patients with severe glucose-6-phosphate dehydrogenase
with methylene blue is generally effective and is enhanced by          deficiency.9 Because glucose-6-phosphate dehydrogenase
monitoring the response to treatment.5 In rural Asia,                  deficiency affects between 3% and 4% of the Sri Lankan
monitoring is unavailable and contributes to the high death            population, therapeutic uncertainty occurs when the clinical
rates after poisoning by some methemoglobinemia-inducing               response is partial or unclear. This uncertainty may contribute
pesticides, in particular the herbicide propanil, which has a 12%      to the high mortality.
mortality rate.6,7                                                         Ideally, the treatment of methemoglobinemia should be
    The recommended dose of methylene blue for the treatment           guided by measurements of methemoglobin levels.9 The
of methemoglobinemia is 1 to 2 mg/kg body weight, but                  objective of this research was to develop and validate a low-cost

184 Annals of Emergency Medicine                                                                       Volume , .  : February 
Shihana et al                                                                            Bedside Test to Determine Methemoglobin

                                                                    measured methemoglobin levels.11 The mean red, green, and
                  Editor’s Capsule Summary
                                                                    blue values were used to prepare a color chart that was
   What is already known on this topic                              subsequently printed.
   The methemoglobin concentration is used to                           The prepared color chart was validated using both scanned
                                                                    and freshly prepared methemoglobin blood samples. Physicians,
   diagnose and guide treatment of
                                                                    preinternship medical graduates, and nonmedical office staff
   methemoglobinemia, but in many countries                         were used as these observers (n 21). Nine scanned
   instruments needed to measure methemoglobin are                  methemoglobin spots (10% to 100%) were randomly given to
   not readily available.                                           observers, who were asked to estimate the methemoglobin
   What question this study addressed                               percentage by matching the sample with a color chart labeled in
                                                                    5% increments. The same methodology was used with 9 freshly
   Can a color chart allow visual clinical estimation of            prepared methemoglobin samples spotted on absorbent
   the methemoglobin concentration at the bedside?                  material. These observers (n 9) had to make an estimate of the
   What this study adds to our knowledge                            methemoglobin percentage within 2 minutes. The testing was
                                                                    performed under fluorescent or tungsten lights, with a distance
   Interobserver agreement using the chart was 94%
                                                                    of about 30 cm from eye levels to color chart. The results were
   on blood samples with methemoglobin                              compared with the actual values of methemoglobin for both
   concentrations of 10% to 80%. Clinical testing in 3              scanned and freshly prepared methemoglobin blood samples,
   hospitals also showed good agreement.                            and agreements of observers’ results with the color chart were
   How this might change clinical practice                          calculated with statistics.
                                                                        The effect of a range of hemoglobin concentrations and
   This color chart can facilitate more rapid diagnosis             methylene blue concentrations in the blood samples was also
   of methemoglobinemia and is of particular value in               assessed in further validations of the color chart. Blood samples
   settings that lack analytic instruments capable of               with an initial known methemoglobin concentration were
   performing this task.                                            incubated with methylene blue. Red, green, and blue values of
                                                                    the samples were measured: before methylene blue, just after
                                                                    addition of methylene blue, and after 1-hour incubation.
bedside test for quantitative estimation of clinically significant       For clinical samples, clinicians used the chart and recorded
methemoglobin to be used in settings of limited resources.          the estimated methemoglobin percentage by using the color
                                                                    chart. Thirteen patients’ methemoglobin levels were estimated
MATERIALS AND METHODS                                               with the color chart, and a blood sample taken at the same time
   A series of experiments was designed to assess the               was analyzed independently with spectrophotometer (Unico
concentration of sodium nitrite necessary for the conversion of     UV-Vis; model UV 2800).
hemoglobin into methemoglobin in the range of 10% to 100%.              The interrater agreement was estimated with the weighted
Variable concentrations of methemoglobin were induced in            statistic with Stata IC 10 (StataCorp, College Station, TX). The
normal blood samples by adding various concentrations of            other analyses were conducted with GraphPad Prism 5, and
sodium nitrite prepared by diluting a 12.41 g/L sodium nitrite      graphs were made with the same software.
stock solution. An equal amount of diluted sodium nitrite was           Ethics approval was obtained from the Ethical Review
added to test tubes containing 1.0 mL of normal blood. The          Committee of the University of Peradeniya, Sri Lanka.
blood sample’s methemoglobin concentration was measured
using the method below, which is based on that of Evelyn and        RESULTS
Malloy.10 Diluted methemoglobin blood samples were prepared            We created a set of blood samples with increasing (10% to
by adding 0.2 mL methemoglobin blood into 10.0 mL of                100%) methemoglobin concentration that showed a gradual
diluents containing phosphate buffer and detergent. The             increase in absorbance at a wavelength of 630 nm. The
absorbance at 630 nm was used to determine the                      conversion of hemoglobin to methemoglobin increased linearly,
methemoglobin concentration.                                        with a corresponding increase of sodium nitrite concentration.
   Red– dark brown blood was observed in the 10% to 100%            The calibration plot (Figure 1) of methemoglobin versus
methemoglobin blood samples. Freshly prepared series of             sodium nitrite concentration yielded an R2 of 0.9987.
methemoglobin samples were placed on a piece of white                  An obvious change in color from red to dark brown was
absorbent material and scanned within 1 minute using a Canon        observed (Figure 2). Measuring the color value of the scanned
Scan LiDE 25 color image scanner (Canon Inc, Vietnam). The          blood drops showed an inverse relationship between red color
color value (from red to brown) of scanned samples was              value and methemoglobin content, with a correlation coefficient
measured using an open source image processing and analysis         of 0.9938 (Figure 3). The red color value changed from 196 to
program ImageJ 1.37v, which allows the mean red, green, and         108 as the methemoglobin levels changed from 10% to 80%;
blue values to be measured directly and then plotted against the    the change in the green and blue color values was negligible.

Volume , .  : February                                                                   Annals of Emergency Medicine 185
Bedside Test to Determine Methemoglobin                                                                               Shihana et al




                                                                  Figure 4. The change in the color value of normal and 40%
                                                                  methemoglobin blood samples. The red color value of
                                                                  blood samples with hemoglobin levels from 9 g/dL to 17
                                                                  g/dL was measured in an Image J program.

Figure 1. Amount of methemoglobin formed with increasing
sodium nitrite concentration.                                     using the color chart. These test-scanned samples were based on
                                                                  spiked samples with a known methemoglobin concentration
                                                                  between 10% and 80%. There was excellent interobserver
                                                                  agreement for scanned methemoglobin samples with this color
                                                                  chart; mean interobserver agreement was 94%, and unweighted
                                                                  and weighted values were 0.37 and 0.83, respectively. The
                                                                  type of light (artificial versus natural) and time of day did not
Figure 2. Samples used to measure red, green, and blue            affect the observers’ ability to estimate methemoglobin color.
values of methemoglobin. A drop (10 L) of blood was               The same procedure with freshly prepared methemoglobin
placed on white absorbent material and scanned with a             blood samples with 9 independent observers also showed high
flatbed Canon Scan LiDE 25 scanner.
                                                                  interobserver agreement (88%) and weighted (0.71).
                                                                      The effect of administration of methylene blue on the color
                                                                  of the blood sample was also studied for further validation of
                                                                  the color chart. Blood samples with an initial known
                                                                  methemoglobin concentration were incubated with methylene
                                                                  blue. Red, green, and blue of the samples were measured before
                                                                  addition of methylene blue, at methylene blue addition, and
                                                                  after 1 hour of incubation (Figure 6). Although there was a
                                                                  significant change in blue color value at methylene blue
                                                                  addition, there was extremely low variation in blue values after
                                                                  an hour of incubation with methylene blue. The low variation at 1
                                                                  hour corresponds to the time when most clinical samples are
                                                                  collected after administration of methylene blue to a patient.
                                                                      The color chart was introduced to 3 hospitals, where 108
                                                                  samples of methemoglobin concentrations were measured in 13
                                                                  patients. Figure 7 shows the Bland-Altman plot for comparison
Figure 3. The variation of red, green, and blue color values
with methemoglobin concentration (%) Scanned                      of methemoglobin concentration measured by
methemoglobin spots were analyzed with an Image J                 spectrophotometer and the color chart for these clinical samples.
program to measure the mean color values.
                                                                  DISCUSSION
                                                                     We have developed and validated a simple bedside test that
    Checking the effect of variation in hemoglobin                can be used to accurately estimate the concentration of
concentration, we found a minimal effect on the red color value   methemoglobin in blood samples and guide clinical
of both methemoglobin and methemoglobin-free blood samples        management. It should be useful in hospitals with limited
in the range of 9 g/dL to 17 g/dL hemoglobin (Figure 4).          resources or in situations in which methemoglobin
    The color chart prepared from the RBG values of the           concentrations cannot be measured rapidly.
standard methemoglobin blood samples is shown in Figure 5.           Blood samples with a methemoglobin concentration greater
The methemoglobin percentage represented by 9 scanned blood       than 20% have a noticeably brown coloration. Previous studies
samples (blots) was estimated by 21 independent observers         have shown that observers can detect the presence of

186 Annals of Emergency Medicine                                                                 Volume , .  : February 
Shihana et al                                                                       Bedside Test to Determine Methemoglobin




Figure 5. Color chart for the measurement of methemoglobin. The color chart was prepared according to the change in
red, green, and blue value of blood samples with known methemoglobin concentration.




Figure 6. Demonstration of the change in red, green, and blue value of blood samples with methylene blue, starting from
a known concentration of methemoglobin A, before methylene blue addition, B, just after methylene blue was added, C,
after incubation with methylene blue for 1 hour.

methemoglobin by using a bedside blood spot test. However, no   unweighted suggests only moderate agreement in terms of the
work has previously tested whether observers can quantify the   precise estimate.13 However, the weighted (which weighs the
methemoglobin concentration.12 Our results indicate that        extent of disagreement) indicates extremely high agreement and
accurate estimates are possible.                                that any difference in estimates was usually very minor. This is
   The interobserver agreement of scanned methemoglobin         clinically important because it allows multiple observers to
blood samples with the color chart was very good. The           detect significant changes in a patient’s methemoglobin

Volume , .  : February                                                               Annals of Emergency Medicine 187
Bedside Test to Determine Methemoglobin                                                                                        Shihana et al

                                                                        sulfhemoglobin or carboxyhemoglobin. Further studies are
                                                                        required to resolve these issues, although they will affect
                                                                        relatively few patients.
                                                                            The results of the study suggest that the red, green, and blue
                                                                        value of scanned blood samples accurately estimates the percentage
                                                                        of methemoglobin present. A color chart produced from these red,
                                                                        green, and blue values can be used to give a clinically meaningful
                                                                        quantitative estimate of the percentage of methemoglobin present
                                                                        in a blood sample taken from a poisoned patient.

                                                                           The authors thank the Teaching Hospital, Peradeniya, for providing
                                                                        research facilities and encouragement. We thank our clinical
                                                                        investigators, Dr. K. S. Kularathne and Dr. I. B. Gawarammana,
                                                                        who provided samples and cared for study patients.
Figure 7. Bland-Altman plots of methemoglobin
concentration estimated by spectrophotometric and color
chart methods. The difference is plotted against the                    Supervising editor: Richard C. Dart, MD, PhD
average of the two methods. Differences from the gold                   Author contributions: FS wrote the first draft of the article,
standard in future patient samples should lie between the               performed all laboratory analyses, analyzed the data, had
limits 95% of the time.                                                 access to all the data in the study, and had final responsibility
                                                                        for the decision to submit for publication. DMD and AHD
concentration and thus allows treatment to be titrated against          designed and set up the study. NAB contributed ideas to
                                                                        design the study. NAB and AHD provided statistical advice on
response. In clinical use, the color chart shows a good agreement
                                                                        study design. All authors had a role in improving the study
in Bland-Altman plot in spite of the aggregation of
                                                                        design and in reviewing and editing the final version of the
methemoglobin concentrations in 5% (Figure 7). Because the              article. FS takes responsibility for the paper as a whole.
agreement between the color chart and the spectrophotometric
method in actual clinical use was high, the color chart can be          Funding and support: By Annals policy, all authors are required
used clinically for the same purposes as a formal laboratory            to disclose any and all commercial, financial, and other
measurement. Changes of more than 10% from a previous                   relationships in any way related to the subject of this article
reading are likely to represent a true change in methemoglobin          that might create any potential conflict of interest. The authors
                                                                        have stated that no such relationships exist. See the
concentration (Figure 7).
                                                                        Manuscript Submission Agreement in this issue for examples
    Our results show that variability in hemoglobin levels or
                                                                        of specific conflicts covered by this statement. This study was
ambient light was not associated with significant variation in the       supported by the South Asian Clinical Toxicology Research
methemoglobin color value. It seemed that any change in color           Collaboration, which is funded by The Wellcome
perception affected both the chart and patient sample equally.          Trust/National Health and Medical Research Council
Because scanners use a consistent light source, we can also             International Collaborative Research Grant GR071669MA. The
assume that red, green, and blue values from scanned spots will         funding bodies had no role in analyzing or interpreting the
always be consistent for a given scanner. However, the color            data or writing the article.
value of the chart also depends on the printer inks and paper
                                                                        Publication dates: Received for publication March 30, 2009.
and might fade with time. We recommend that printed versions
                                                                        Revision received June 9, 2009. Accepted for publication July
of the color chart periodically be rescanned with a scanner and         22, 2009. Available online October 8, 2009.
checked against the original red, green, and blue values shown
in Figures 3 and 5.                                                     Reprints not available from the authors.
    Although there is a potential effect of methylene blue on the       Address for correspondence: Fathima Shihana, BSc, South
color of the blood sample, we did not observe any significant            Asian Clinical Toxicology Research Collaboration, Faculty of
effect 1 hour after administration. Even within an hour it is           Medicine, University of Peradeniya, Sri Lanka; 94-081-
likely that a relative change in methemoglobin with methylene           4479822, fax 94-081-4479822; E-mail shihana@sactrc.org.
blue would still be detectable even if the actual estimates were
less accurate. In any case, there is little clinical justification for
taking repeated methemoglobin estimation within an hour of              REFERENCES
methylene blue administration.                                           1. Singh H, Purnell E, Smith C. Mechanistic study on aniline-induced
                                                                            erythrocyte toxicity. Arh Hig Rada Toksikol. 2007;58:275-285.
    Abnormal hemoglobins such as hemoglobin M may affect
                                                                         2. Anderson CM, Woodside KJ, Spencer TA, et al.
the color value because they are known to interfere with                    Methemoglobinemia: an unusual cause of postoperative cyanosis.
estimates by co-oximetry.14 Similarly, some causes of                       J Vasc Surg. 2004;39:686-690.
methemoglobin cause the formation of small amounts of                    3. Camp NE. Methemoglobinemia. J Emerg Nurs. 2007;33:172-174.


188 Annals of Emergency Medicine                                                                          Volume , .  : February 
Shihana et al                                                                                    Bedside Test to Determine Methemoglobin

 4. Fernando R. Managment of Poisoning. 3rd ed. Colombo, Sri              9. Watcha MF, Connor MT, Hing AV. Pulse oximetry in
    Lanka: National Poison Information Centre National Hospital of Sri       methemoglobinemia. Am J Dis Child. 1989;143:845-847.
    Lanka; 2007.                                                         10. Dacie J. Practical Haematology. 6th ed. New York, NY: Churchill
 5. Cattaneo A, Furiosi D, Bolis C, et al. [Acute poisoning caused by        Livingstone. 1984:148-149.
    methemoglobinemia-inducing substances. 6 cases]. Minerva Med.        11. Rasband W. ImageJ. v. 1.37. National Institutes of Health. Available at:
    1987;78:1167-1176.                                                       http://rsbweb.nih.gov/ij/index.html.2006. Accessed August 19, 2009.
 6. Eddleston M, Rajapakshe M, Roberts D, et al. Severe propanil         12. Harvey JW. Pathogenesis, laboratory diagnosis, and clinical
    [N-(3,4-dichlorophenyl) propanamide] pesticide self-poisoning. J         implications of erythrocyte enzyme deficiencies in dogs, cats, and
    Toxicol Clin Toxicol. 2002;40:847-854.                                   horses. Vet Clin Pathol. 2006;35:144-156.
 7. De Silva WA, Bodinayake CK. Propanil poisoning. Ceylon Med J.        13. Chmura Kraemer H, Periyakoil VS, Noda A. Kappa coefficients in
    1997;42:81-84.                                                           medical research. Stat Med. 2002;21:2109-2129.
 8. Roberts DM, Heilmair R, Buckley NA, et al. Clinical outcomes and     14. Haymond S, Cariappa R, Eby CS, et al. Laboratory assessment
    kinetics of propanil following acute self-poisoning: a prospective       of oxygenation in methemoglobinemia. Clin Chem. 2005;51:
    case series. BMC Clin Pharmacol. 2009;9:3.                               434-444.




                                                              Did you know?
                               Annals accepts audio and video files as ancillaries to the main article.
                  Visit http://www.annemergmed.com/content/instauth/ for more details!


Volume , .  : February                                                                             Annals of Emergency Medicine 189

Mais conteúdo relacionado

Mais procurados

Method development and validation for the estimation of metronidazole in tabl...
Method development and validation for the estimation of metronidazole in tabl...Method development and validation for the estimation of metronidazole in tabl...
Method development and validation for the estimation of metronidazole in tabl...pharmaindexing
 
naltrexone and buropion RP-HPLC best research paper award 2014
naltrexone and buropion RP-HPLC best research paper award 2014 naltrexone and buropion RP-HPLC best research paper award 2014
naltrexone and buropion RP-HPLC best research paper award 2014 Naveen Chennamaneni
 
Pharmacokinetic study of epileptic patients
Pharmacokinetic study of epileptic patientsPharmacokinetic study of epileptic patients
Pharmacokinetic study of epileptic patientssaima rani
 
An emerging way of estimation of Olmesartan medoxomil & Hydrochlorothiazide i...
An emerging way of estimation of Olmesartan medoxomil & Hydrochlorothiazide i...An emerging way of estimation of Olmesartan medoxomil & Hydrochlorothiazide i...
An emerging way of estimation of Olmesartan medoxomil & Hydrochlorothiazide i...Priyanka Bose
 
Rapid Reverse-phase High-performance Liquid Chromatography Estimation of Meth...
Rapid Reverse-phase High-performance Liquid Chromatography Estimation of Meth...Rapid Reverse-phase High-performance Liquid Chromatography Estimation of Meth...
Rapid Reverse-phase High-performance Liquid Chromatography Estimation of Meth...BRNSS Publication Hub
 
Stability indicating RP-HPLC method for estimation of dapagliflozin in bulk a...
Stability indicating RP-HPLC method for estimation of dapagliflozin in bulk a...Stability indicating RP-HPLC method for estimation of dapagliflozin in bulk a...
Stability indicating RP-HPLC method for estimation of dapagliflozin in bulk a...SriramNagarajan19
 
UV Spectrophotometric Method Development and Validation for Quantitative Esti...
UV Spectrophotometric Method Development and Validation for Quantitative Esti...UV Spectrophotometric Method Development and Validation for Quantitative Esti...
UV Spectrophotometric Method Development and Validation for Quantitative Esti...Sagar Savale
 
Method Development and Validation of Naftopidil by Reverse Phase-HPLC in Bulk...
Method Development and Validation of Naftopidil by Reverse Phase-HPLC in Bulk...Method Development and Validation of Naftopidil by Reverse Phase-HPLC in Bulk...
Method Development and Validation of Naftopidil by Reverse Phase-HPLC in Bulk...SriramNagarajan15
 
Method Development and Validation of Naftopidil by Reverse Phase-HPLC in Bulk...
Method Development and Validation of Naftopidil by Reverse Phase-HPLC in Bulk...Method Development and Validation of Naftopidil by Reverse Phase-HPLC in Bulk...
Method Development and Validation of Naftopidil by Reverse Phase-HPLC in Bulk...pharmaindexing
 
Pharmacokinetics of High-Dose Methotrexate in Egyptian Children with Acute Ly...
Pharmacokinetics of High-Dose Methotrexate in Egyptian Children with Acute Ly...Pharmacokinetics of High-Dose Methotrexate in Egyptian Children with Acute Ly...
Pharmacokinetics of High-Dose Methotrexate in Egyptian Children with Acute Ly...iosrphr_editor
 
Method Development and Validation for Simultaneous estimation of Metformin Hc...
Method Development and Validation for Simultaneous estimation of Metformin Hc...Method Development and Validation for Simultaneous estimation of Metformin Hc...
Method Development and Validation for Simultaneous estimation of Metformin Hc...pharmaindexing
 
Determination of metronidazole from the solid dosage form
Determination of metronidazole from the solid dosage formDetermination of metronidazole from the solid dosage form
Determination of metronidazole from the solid dosage formAtai Rabby
 
Method Development and Validation for Simultaneous Estimation of Dasatinib an...
Method Development and Validation for Simultaneous Estimation of Dasatinib an...Method Development and Validation for Simultaneous Estimation of Dasatinib an...
Method Development and Validation for Simultaneous Estimation of Dasatinib an...YogeshIJTSRD
 
Adaptive method OR dosing with feedback
Adaptive method OR dosing with feedbackAdaptive method OR dosing with feedback
Adaptive method OR dosing with feedbackpavithra vinayak
 
Development of RP-HPLC method for simultaneous estimation of gemifloxacin and...
Development of RP-HPLC method for simultaneous estimation of gemifloxacin and...Development of RP-HPLC method for simultaneous estimation of gemifloxacin and...
Development of RP-HPLC method for simultaneous estimation of gemifloxacin and...SriramNagarajan17
 
020203 ps0096
020203 ps0096020203 ps0096
020203 ps0096Jing Zang
 

Mais procurados (20)

Method development and validation for the estimation of metronidazole in tabl...
Method development and validation for the estimation of metronidazole in tabl...Method development and validation for the estimation of metronidazole in tabl...
Method development and validation for the estimation of metronidazole in tabl...
 
naltrexone and buropion RP-HPLC best research paper award 2014
naltrexone and buropion RP-HPLC best research paper award 2014 naltrexone and buropion RP-HPLC best research paper award 2014
naltrexone and buropion RP-HPLC best research paper award 2014
 
Pharmacokinetic study of epileptic patients
Pharmacokinetic study of epileptic patientsPharmacokinetic study of epileptic patients
Pharmacokinetic study of epileptic patients
 
An emerging way of estimation of Olmesartan medoxomil & Hydrochlorothiazide i...
An emerging way of estimation of Olmesartan medoxomil & Hydrochlorothiazide i...An emerging way of estimation of Olmesartan medoxomil & Hydrochlorothiazide i...
An emerging way of estimation of Olmesartan medoxomil & Hydrochlorothiazide i...
 
E0412020025
E0412020025E0412020025
E0412020025
 
Rapid Reverse-phase High-performance Liquid Chromatography Estimation of Meth...
Rapid Reverse-phase High-performance Liquid Chromatography Estimation of Meth...Rapid Reverse-phase High-performance Liquid Chromatography Estimation of Meth...
Rapid Reverse-phase High-performance Liquid Chromatography Estimation of Meth...
 
Stability indicating RP-HPLC method for estimation of dapagliflozin in bulk a...
Stability indicating RP-HPLC method for estimation of dapagliflozin in bulk a...Stability indicating RP-HPLC method for estimation of dapagliflozin in bulk a...
Stability indicating RP-HPLC method for estimation of dapagliflozin in bulk a...
 
MpM
MpMMpM
MpM
 
UV Spectrophotometric Method Development and Validation for Quantitative Esti...
UV Spectrophotometric Method Development and Validation for Quantitative Esti...UV Spectrophotometric Method Development and Validation for Quantitative Esti...
UV Spectrophotometric Method Development and Validation for Quantitative Esti...
 
Method Development and Validation of Naftopidil by Reverse Phase-HPLC in Bulk...
Method Development and Validation of Naftopidil by Reverse Phase-HPLC in Bulk...Method Development and Validation of Naftopidil by Reverse Phase-HPLC in Bulk...
Method Development and Validation of Naftopidil by Reverse Phase-HPLC in Bulk...
 
Method Development and Validation of Naftopidil by Reverse Phase-HPLC in Bulk...
Method Development and Validation of Naftopidil by Reverse Phase-HPLC in Bulk...Method Development and Validation of Naftopidil by Reverse Phase-HPLC in Bulk...
Method Development and Validation of Naftopidil by Reverse Phase-HPLC in Bulk...
 
Pharmacokinetics of High-Dose Methotrexate in Egyptian Children with Acute Ly...
Pharmacokinetics of High-Dose Methotrexate in Egyptian Children with Acute Ly...Pharmacokinetics of High-Dose Methotrexate in Egyptian Children with Acute Ly...
Pharmacokinetics of High-Dose Methotrexate in Egyptian Children with Acute Ly...
 
Method Development and Validation for Simultaneous estimation of Metformin Hc...
Method Development and Validation for Simultaneous estimation of Metformin Hc...Method Development and Validation for Simultaneous estimation of Metformin Hc...
Method Development and Validation for Simultaneous estimation of Metformin Hc...
 
JPR2010_TDMB
JPR2010_TDMBJPR2010_TDMB
JPR2010_TDMB
 
Determination of metronidazole from the solid dosage form
Determination of metronidazole from the solid dosage formDetermination of metronidazole from the solid dosage form
Determination of metronidazole from the solid dosage form
 
Sampath
SampathSampath
Sampath
 
Method Development and Validation for Simultaneous Estimation of Dasatinib an...
Method Development and Validation for Simultaneous Estimation of Dasatinib an...Method Development and Validation for Simultaneous Estimation of Dasatinib an...
Method Development and Validation for Simultaneous Estimation of Dasatinib an...
 
Adaptive method OR dosing with feedback
Adaptive method OR dosing with feedbackAdaptive method OR dosing with feedback
Adaptive method OR dosing with feedback
 
Development of RP-HPLC method for simultaneous estimation of gemifloxacin and...
Development of RP-HPLC method for simultaneous estimation of gemifloxacin and...Development of RP-HPLC method for simultaneous estimation of gemifloxacin and...
Development of RP-HPLC method for simultaneous estimation of gemifloxacin and...
 
020203 ps0096
020203 ps0096020203 ps0096
020203 ps0096
 

Semelhante a A Simple Quantitative Bedside Test to Determine Methemoglobin

Differential spectrophotometric method for estimation and validation of Verap...
Differential spectrophotometric method for estimation and validation of Verap...Differential spectrophotometric method for estimation and validation of Verap...
Differential spectrophotometric method for estimation and validation of Verap...roshan telrandhe
 
Painful Poster Revised Sjm Edits
Painful Poster Revised Sjm EditsPainful Poster Revised Sjm Edits
Painful Poster Revised Sjm Editsgnatgirl
 
THE JOURNAL CLUB venkat 2 pharmaceutical analysis
THE JOURNAL CLUB venkat 2 pharmaceutical analysisTHE JOURNAL CLUB venkat 2 pharmaceutical analysis
THE JOURNAL CLUB venkat 2 pharmaceutical analysisVenkatesan R - 6369851191
 
Analytical Method Development and Validation for Simultaneous Estimation of L...
Analytical Method Development and Validation for Simultaneous Estimation of L...Analytical Method Development and Validation for Simultaneous Estimation of L...
Analytical Method Development and Validation for Simultaneous Estimation of L...pharmaindexing
 
DM Garby_Clozapine AACC 2008
DM Garby_Clozapine AACC 2008DM Garby_Clozapine AACC 2008
DM Garby_Clozapine AACC 2008David Garby
 
Bioequivalence
BioequivalenceBioequivalence
BioequivalenceGaurav Kr
 
Bioequivalence
BioequivalenceBioequivalence
BioequivalenceGaurav Kr
 
Integrated hemolysis monitoring for bottom-up protein bioanalysis
Integrated hemolysis monitoring for bottom-up protein bioanalysisIntegrated hemolysis monitoring for bottom-up protein bioanalysis
Integrated hemolysis monitoring for bottom-up protein bioanalysisAnne Kleinnijenhuis
 
Methehemoglobin
MethehemoglobinMethehemoglobin
MethehemoglobinMarai_44
 
Stability indicating method and validation for the simultaneous estimation of...
Stability indicating method and validation for the simultaneous estimation of...Stability indicating method and validation for the simultaneous estimation of...
Stability indicating method and validation for the simultaneous estimation of...SriramNagarajan18
 
SIMULTANEOUS QUANTIFICATION OF TELMISARTAN AND METOPROLOL SUCCINATE IN TABLET...
SIMULTANEOUS QUANTIFICATION OF TELMISARTAN AND METOPROLOL SUCCINATE IN TABLET...SIMULTANEOUS QUANTIFICATION OF TELMISARTAN AND METOPROLOL SUCCINATE IN TABLET...
SIMULTANEOUS QUANTIFICATION OF TELMISARTAN AND METOPROLOL SUCCINATE IN TABLET...Jing Zang
 
Method Development and Validation of Naftopidil by Reverse Phase-HPLC in Bulk...
Method Development and Validation of Naftopidil by Reverse Phase-HPLC in Bulk...Method Development and Validation of Naftopidil by Reverse Phase-HPLC in Bulk...
Method Development and Validation of Naftopidil by Reverse Phase-HPLC in Bulk...SriramNagarajan15
 
Recent control and testing strategies for genotoxic impurities
Recent control and testing strategies for genotoxic impuritiesRecent control and testing strategies for genotoxic impurities
Recent control and testing strategies for genotoxic impuritiesVeeprho Pharmaceuticals Pvt.Ltd
 
Simultaneous estimation of metformin hydrochloride and glibenclamide by rphpl...
Simultaneous estimation of metformin hydrochloride and glibenclamide by rphpl...Simultaneous estimation of metformin hydrochloride and glibenclamide by rphpl...
Simultaneous estimation of metformin hydrochloride and glibenclamide by rphpl...IJSIT Editor
 
Applications of mass spectrometry.seminar.pptx
Applications of mass spectrometry.seminar.pptxApplications of mass spectrometry.seminar.pptx
Applications of mass spectrometry.seminar.pptxAsif Shaikh
 
Therapeutic Drug Monitoring
Therapeutic Drug MonitoringTherapeutic Drug Monitoring
Therapeutic Drug MonitoringTulasi Raman
 
pdtt presentation.pptx
pdtt presentation.pptxpdtt presentation.pptx
pdtt presentation.pptxDeepali69
 

Semelhante a A Simple Quantitative Bedside Test to Determine Methemoglobin (20)

Differential spectrophotometric method for estimation and validation of Verap...
Differential spectrophotometric method for estimation and validation of Verap...Differential spectrophotometric method for estimation and validation of Verap...
Differential spectrophotometric method for estimation and validation of Verap...
 
Painful Poster Revised Sjm Edits
Painful Poster Revised Sjm EditsPainful Poster Revised Sjm Edits
Painful Poster Revised Sjm Edits
 
THE JOURNAL CLUB venkat 2 pharmaceutical analysis
THE JOURNAL CLUB venkat 2 pharmaceutical analysisTHE JOURNAL CLUB venkat 2 pharmaceutical analysis
THE JOURNAL CLUB venkat 2 pharmaceutical analysis
 
Analytical Method Development and Validation for Simultaneous Estimation of L...
Analytical Method Development and Validation for Simultaneous Estimation of L...Analytical Method Development and Validation for Simultaneous Estimation of L...
Analytical Method Development and Validation for Simultaneous Estimation of L...
 
DM Garby_Clozapine AACC 2008
DM Garby_Clozapine AACC 2008DM Garby_Clozapine AACC 2008
DM Garby_Clozapine AACC 2008
 
Bioequivalence
BioequivalenceBioequivalence
Bioequivalence
 
Bioequivalence
BioequivalenceBioequivalence
Bioequivalence
 
Integrated hemolysis monitoring for bottom-up protein bioanalysis
Integrated hemolysis monitoring for bottom-up protein bioanalysisIntegrated hemolysis monitoring for bottom-up protein bioanalysis
Integrated hemolysis monitoring for bottom-up protein bioanalysis
 
Methehemoglobin
MethehemoglobinMethehemoglobin
Methehemoglobin
 
Stability indicating method and validation for the simultaneous estimation of...
Stability indicating method and validation for the simultaneous estimation of...Stability indicating method and validation for the simultaneous estimation of...
Stability indicating method and validation for the simultaneous estimation of...
 
SIMULTANEOUS QUANTIFICATION OF TELMISARTAN AND METOPROLOL SUCCINATE IN TABLET...
SIMULTANEOUS QUANTIFICATION OF TELMISARTAN AND METOPROLOL SUCCINATE IN TABLET...SIMULTANEOUS QUANTIFICATION OF TELMISARTAN AND METOPROLOL SUCCINATE IN TABLET...
SIMULTANEOUS QUANTIFICATION OF TELMISARTAN AND METOPROLOL SUCCINATE IN TABLET...
 
E04602033038
E04602033038E04602033038
E04602033038
 
Method Development and Validation of Naftopidil by Reverse Phase-HPLC in Bulk...
Method Development and Validation of Naftopidil by Reverse Phase-HPLC in Bulk...Method Development and Validation of Naftopidil by Reverse Phase-HPLC in Bulk...
Method Development and Validation of Naftopidil by Reverse Phase-HPLC in Bulk...
 
Recent control and testing strategies for genotoxic impurities
Recent control and testing strategies for genotoxic impuritiesRecent control and testing strategies for genotoxic impurities
Recent control and testing strategies for genotoxic impurities
 
Simultaneous estimation of metformin hydrochloride and glibenclamide by rphpl...
Simultaneous estimation of metformin hydrochloride and glibenclamide by rphpl...Simultaneous estimation of metformin hydrochloride and glibenclamide by rphpl...
Simultaneous estimation of metformin hydrochloride and glibenclamide by rphpl...
 
Applications of mass spectrometry.seminar.pptx
Applications of mass spectrometry.seminar.pptxApplications of mass spectrometry.seminar.pptx
Applications of mass spectrometry.seminar.pptx
 
E0552228
E0552228E0552228
E0552228
 
Bioassays
Bioassays Bioassays
Bioassays
 
Therapeutic Drug Monitoring
Therapeutic Drug MonitoringTherapeutic Drug Monitoring
Therapeutic Drug Monitoring
 
pdtt presentation.pptx
pdtt presentation.pptxpdtt presentation.pptx
pdtt presentation.pptx
 

Mais de EM OMSB

Case presentation
Case presentationCase presentation
Case presentationEM OMSB
 
Heroic procedures you should know
Heroic procedures you should knowHeroic procedures you should know
Heroic procedures you should knowEM OMSB
 
Ed overcrowding
Ed overcrowdingEd overcrowding
Ed overcrowdingEM OMSB
 
challenge rash
 challenge rash challenge rash
challenge rashEM OMSB
 
Case Presenation
Case PresenationCase Presenation
Case PresenationEM OMSB
 
Clinical Series Pesticide
Clinical Series PesticideClinical Series Pesticide
Clinical Series PesticideEM OMSB
 
The seizing patient
The seizing patientThe seizing patient
The seizing patientEM OMSB
 
Coccain and Sympathomimatic
Coccain and Sympathomimatic Coccain and Sympathomimatic
Coccain and Sympathomimatic EM OMSB
 
Case presentation
Case presentationCase presentation
Case presentationEM OMSB
 
Venomous marine
Venomous marineVenomous marine
Venomous marineEM OMSB
 
Optimzing sepsis management
Optimzing sepsis managementOptimzing sepsis management
Optimzing sepsis managementEM OMSB
 
Heavy metals iron and lithium
Heavy metals iron and lithiumHeavy metals iron and lithium
Heavy metals iron and lithiumEM OMSB
 
Antibiotic in ED
Antibiotic in EDAntibiotic in ED
Antibiotic in EDEM OMSB
 
Aortic disasters ahmed
Aortic disasters ahmedAortic disasters ahmed
Aortic disasters ahmedEM OMSB
 
Case Presentation
Case Presentation Case Presentation
Case Presentation EM OMSB
 
Clinical emergency procedures Chest Tube
Clinical emergency procedures Chest TubeClinical emergency procedures Chest Tube
Clinical emergency procedures Chest TubeEM OMSB
 
Resuscitation in special populations
Resuscitation in special populationsResuscitation in special populations
Resuscitation in special populationsEM OMSB
 
NIV updated
NIV updatedNIV updated
NIV updatedEM OMSB
 
RAA SEPT 7TH
RAA SEPT 7THRAA SEPT 7TH
RAA SEPT 7THEM OMSB
 
Raa blog
Raa blogRaa blog
Raa blogEM OMSB
 

Mais de EM OMSB (20)

Case presentation
Case presentationCase presentation
Case presentation
 
Heroic procedures you should know
Heroic procedures you should knowHeroic procedures you should know
Heroic procedures you should know
 
Ed overcrowding
Ed overcrowdingEd overcrowding
Ed overcrowding
 
challenge rash
 challenge rash challenge rash
challenge rash
 
Case Presenation
Case PresenationCase Presenation
Case Presenation
 
Clinical Series Pesticide
Clinical Series PesticideClinical Series Pesticide
Clinical Series Pesticide
 
The seizing patient
The seizing patientThe seizing patient
The seizing patient
 
Coccain and Sympathomimatic
Coccain and Sympathomimatic Coccain and Sympathomimatic
Coccain and Sympathomimatic
 
Case presentation
Case presentationCase presentation
Case presentation
 
Venomous marine
Venomous marineVenomous marine
Venomous marine
 
Optimzing sepsis management
Optimzing sepsis managementOptimzing sepsis management
Optimzing sepsis management
 
Heavy metals iron and lithium
Heavy metals iron and lithiumHeavy metals iron and lithium
Heavy metals iron and lithium
 
Antibiotic in ED
Antibiotic in EDAntibiotic in ED
Antibiotic in ED
 
Aortic disasters ahmed
Aortic disasters ahmedAortic disasters ahmed
Aortic disasters ahmed
 
Case Presentation
Case Presentation Case Presentation
Case Presentation
 
Clinical emergency procedures Chest Tube
Clinical emergency procedures Chest TubeClinical emergency procedures Chest Tube
Clinical emergency procedures Chest Tube
 
Resuscitation in special populations
Resuscitation in special populationsResuscitation in special populations
Resuscitation in special populations
 
NIV updated
NIV updatedNIV updated
NIV updated
 
RAA SEPT 7TH
RAA SEPT 7THRAA SEPT 7TH
RAA SEPT 7TH
 
Raa blog
Raa blogRaa blog
Raa blog
 

A Simple Quantitative Bedside Test to Determine Methemoglobin

  • 1. TOXICOLOGY/ORIGINAL RESEARCH A Simple Quantitative Bedside Test to Determine Methemoglobin Fathima Shihana, BSc From the South Asian Clinical Toxicology Research Collaboration (Shihana, Dissanayake, Buckley, Dhammika Menike Dawson) and Department of Pathology, Faculty of Medicine (Shihana, Dissanayake), University of Peradeniya, Peradeniya, Sri Lanka; The POW Clinical School, University of New South Wales, Dissanayake, MD, PhD Sydney, Australia (Buckley); and the School of Population Health, University of Newcastle, Nicholas Allan Buckley, MD, Newcastle, Australia (Dawson). FRACP Andrew Hamilton Dawson, FRACP, FRCP Study objective: Methemoglobinemia after pesticide poisoning is associated with a mortality of 12% in Sri Lanka. Treatment is complicated by the lack of laboratory facilities. We aimed to develop and validate a low-cost bedside test for quantitative estimation of clinically significant methemoglobin to be used in settings of limited resources. Methods: A method to reliably produce blood samples with 10% to 100% methemoglobin was developed. Freshly prepared methemoglobin samples were used to develop the color chart. One drop (10 L) of prepared methemoglobin sample was placed on white absorbent paper and scanned using a flatbed Cannon Scan LiDE 25 scanner. The mean red, green, and blue values were measured with ImageJ 1.37v. These color values were used to prepare a color chart to be used at the bedside. Interobserver agreement was assessed against prepared samples. The results from clinical use were compared with formal methemoglobin measurements. Results: The red color value was linearly related to percentage methemoglobin (R2 0.9938), with no effect of absolute hemoglobin concentration. Mean interobserver (N 21) agreement and weighted for scanned methemoglobin spots using the color chart were 94% and 0.83, respectively. Mean interobserver (N 9) agreement and weighted for a freshly prepared methemoglobin sample with the chart were 88% and 0.71, respectively. Clinical use of the color chart also showed good agreement with spectrometric measurements. Conclusion: A color chart can be used to give a clinically useful quantitative estimate of methemoglobinemia. [Ann Emerg Med. 2010;55:184-189.] Please see page 185 for the Editor’s Capsule Summary of this article. Provide feedback on this article at the journal’s Web site, www.annemergmed.com. 0196-0644/$-see front matter Copyright © 2009 by the American College of Emergency Physicians. doi:10.1016/j.annemergmed.2009.07.022 INTRODUCTION recurrence is common and repeated dosing is required for some Methemoglobinemia can be a life-threatening complication patients.8 However, doses of greater than 4 mg/kg methylene after exposure to a range of chemicals such as nitrates, nitrites, blue may actually exacerbate the methemoglobinemia, especially and aniline and drugs such as dapsone.1-4 Antidote treatment in patients with severe glucose-6-phosphate dehydrogenase with methylene blue is generally effective and is enhanced by deficiency.9 Because glucose-6-phosphate dehydrogenase monitoring the response to treatment.5 In rural Asia, deficiency affects between 3% and 4% of the Sri Lankan monitoring is unavailable and contributes to the high death population, therapeutic uncertainty occurs when the clinical rates after poisoning by some methemoglobinemia-inducing response is partial or unclear. This uncertainty may contribute pesticides, in particular the herbicide propanil, which has a 12% to the high mortality. mortality rate.6,7 Ideally, the treatment of methemoglobinemia should be The recommended dose of methylene blue for the treatment guided by measurements of methemoglobin levels.9 The of methemoglobinemia is 1 to 2 mg/kg body weight, but objective of this research was to develop and validate a low-cost 184 Annals of Emergency Medicine Volume , .  : February 
  • 2. Shihana et al Bedside Test to Determine Methemoglobin measured methemoglobin levels.11 The mean red, green, and Editor’s Capsule Summary blue values were used to prepare a color chart that was What is already known on this topic subsequently printed. The methemoglobin concentration is used to The prepared color chart was validated using both scanned and freshly prepared methemoglobin blood samples. Physicians, diagnose and guide treatment of preinternship medical graduates, and nonmedical office staff methemoglobinemia, but in many countries were used as these observers (n 21). Nine scanned instruments needed to measure methemoglobin are methemoglobin spots (10% to 100%) were randomly given to not readily available. observers, who were asked to estimate the methemoglobin What question this study addressed percentage by matching the sample with a color chart labeled in 5% increments. The same methodology was used with 9 freshly Can a color chart allow visual clinical estimation of prepared methemoglobin samples spotted on absorbent the methemoglobin concentration at the bedside? material. These observers (n 9) had to make an estimate of the What this study adds to our knowledge methemoglobin percentage within 2 minutes. The testing was performed under fluorescent or tungsten lights, with a distance Interobserver agreement using the chart was 94% of about 30 cm from eye levels to color chart. The results were on blood samples with methemoglobin compared with the actual values of methemoglobin for both concentrations of 10% to 80%. Clinical testing in 3 scanned and freshly prepared methemoglobin blood samples, hospitals also showed good agreement. and agreements of observers’ results with the color chart were How this might change clinical practice calculated with statistics. The effect of a range of hemoglobin concentrations and This color chart can facilitate more rapid diagnosis methylene blue concentrations in the blood samples was also of methemoglobinemia and is of particular value in assessed in further validations of the color chart. Blood samples settings that lack analytic instruments capable of with an initial known methemoglobin concentration were performing this task. incubated with methylene blue. Red, green, and blue values of the samples were measured: before methylene blue, just after addition of methylene blue, and after 1-hour incubation. bedside test for quantitative estimation of clinically significant For clinical samples, clinicians used the chart and recorded methemoglobin to be used in settings of limited resources. the estimated methemoglobin percentage by using the color chart. Thirteen patients’ methemoglobin levels were estimated MATERIALS AND METHODS with the color chart, and a blood sample taken at the same time A series of experiments was designed to assess the was analyzed independently with spectrophotometer (Unico concentration of sodium nitrite necessary for the conversion of UV-Vis; model UV 2800). hemoglobin into methemoglobin in the range of 10% to 100%. The interrater agreement was estimated with the weighted Variable concentrations of methemoglobin were induced in statistic with Stata IC 10 (StataCorp, College Station, TX). The normal blood samples by adding various concentrations of other analyses were conducted with GraphPad Prism 5, and sodium nitrite prepared by diluting a 12.41 g/L sodium nitrite graphs were made with the same software. stock solution. An equal amount of diluted sodium nitrite was Ethics approval was obtained from the Ethical Review added to test tubes containing 1.0 mL of normal blood. The Committee of the University of Peradeniya, Sri Lanka. blood sample’s methemoglobin concentration was measured using the method below, which is based on that of Evelyn and RESULTS Malloy.10 Diluted methemoglobin blood samples were prepared We created a set of blood samples with increasing (10% to by adding 0.2 mL methemoglobin blood into 10.0 mL of 100%) methemoglobin concentration that showed a gradual diluents containing phosphate buffer and detergent. The increase in absorbance at a wavelength of 630 nm. The absorbance at 630 nm was used to determine the conversion of hemoglobin to methemoglobin increased linearly, methemoglobin concentration. with a corresponding increase of sodium nitrite concentration. Red– dark brown blood was observed in the 10% to 100% The calibration plot (Figure 1) of methemoglobin versus methemoglobin blood samples. Freshly prepared series of sodium nitrite concentration yielded an R2 of 0.9987. methemoglobin samples were placed on a piece of white An obvious change in color from red to dark brown was absorbent material and scanned within 1 minute using a Canon observed (Figure 2). Measuring the color value of the scanned Scan LiDE 25 color image scanner (Canon Inc, Vietnam). The blood drops showed an inverse relationship between red color color value (from red to brown) of scanned samples was value and methemoglobin content, with a correlation coefficient measured using an open source image processing and analysis of 0.9938 (Figure 3). The red color value changed from 196 to program ImageJ 1.37v, which allows the mean red, green, and 108 as the methemoglobin levels changed from 10% to 80%; blue values to be measured directly and then plotted against the the change in the green and blue color values was negligible. Volume , .  : February  Annals of Emergency Medicine 185
  • 3. Bedside Test to Determine Methemoglobin Shihana et al Figure 4. The change in the color value of normal and 40% methemoglobin blood samples. The red color value of blood samples with hemoglobin levels from 9 g/dL to 17 g/dL was measured in an Image J program. Figure 1. Amount of methemoglobin formed with increasing sodium nitrite concentration. using the color chart. These test-scanned samples were based on spiked samples with a known methemoglobin concentration between 10% and 80%. There was excellent interobserver agreement for scanned methemoglobin samples with this color chart; mean interobserver agreement was 94%, and unweighted and weighted values were 0.37 and 0.83, respectively. The type of light (artificial versus natural) and time of day did not Figure 2. Samples used to measure red, green, and blue affect the observers’ ability to estimate methemoglobin color. values of methemoglobin. A drop (10 L) of blood was The same procedure with freshly prepared methemoglobin placed on white absorbent material and scanned with a blood samples with 9 independent observers also showed high flatbed Canon Scan LiDE 25 scanner. interobserver agreement (88%) and weighted (0.71). The effect of administration of methylene blue on the color of the blood sample was also studied for further validation of the color chart. Blood samples with an initial known methemoglobin concentration were incubated with methylene blue. Red, green, and blue of the samples were measured before addition of methylene blue, at methylene blue addition, and after 1 hour of incubation (Figure 6). Although there was a significant change in blue color value at methylene blue addition, there was extremely low variation in blue values after an hour of incubation with methylene blue. The low variation at 1 hour corresponds to the time when most clinical samples are collected after administration of methylene blue to a patient. The color chart was introduced to 3 hospitals, where 108 samples of methemoglobin concentrations were measured in 13 patients. Figure 7 shows the Bland-Altman plot for comparison Figure 3. The variation of red, green, and blue color values with methemoglobin concentration (%) Scanned of methemoglobin concentration measured by methemoglobin spots were analyzed with an Image J spectrophotometer and the color chart for these clinical samples. program to measure the mean color values. DISCUSSION We have developed and validated a simple bedside test that Checking the effect of variation in hemoglobin can be used to accurately estimate the concentration of concentration, we found a minimal effect on the red color value methemoglobin in blood samples and guide clinical of both methemoglobin and methemoglobin-free blood samples management. It should be useful in hospitals with limited in the range of 9 g/dL to 17 g/dL hemoglobin (Figure 4). resources or in situations in which methemoglobin The color chart prepared from the RBG values of the concentrations cannot be measured rapidly. standard methemoglobin blood samples is shown in Figure 5. Blood samples with a methemoglobin concentration greater The methemoglobin percentage represented by 9 scanned blood than 20% have a noticeably brown coloration. Previous studies samples (blots) was estimated by 21 independent observers have shown that observers can detect the presence of 186 Annals of Emergency Medicine Volume , .  : February 
  • 4. Shihana et al Bedside Test to Determine Methemoglobin Figure 5. Color chart for the measurement of methemoglobin. The color chart was prepared according to the change in red, green, and blue value of blood samples with known methemoglobin concentration. Figure 6. Demonstration of the change in red, green, and blue value of blood samples with methylene blue, starting from a known concentration of methemoglobin A, before methylene blue addition, B, just after methylene blue was added, C, after incubation with methylene blue for 1 hour. methemoglobin by using a bedside blood spot test. However, no unweighted suggests only moderate agreement in terms of the work has previously tested whether observers can quantify the precise estimate.13 However, the weighted (which weighs the methemoglobin concentration.12 Our results indicate that extent of disagreement) indicates extremely high agreement and accurate estimates are possible. that any difference in estimates was usually very minor. This is The interobserver agreement of scanned methemoglobin clinically important because it allows multiple observers to blood samples with the color chart was very good. The detect significant changes in a patient’s methemoglobin Volume , .  : February  Annals of Emergency Medicine 187
  • 5. Bedside Test to Determine Methemoglobin Shihana et al sulfhemoglobin or carboxyhemoglobin. Further studies are required to resolve these issues, although they will affect relatively few patients. The results of the study suggest that the red, green, and blue value of scanned blood samples accurately estimates the percentage of methemoglobin present. A color chart produced from these red, green, and blue values can be used to give a clinically meaningful quantitative estimate of the percentage of methemoglobin present in a blood sample taken from a poisoned patient. The authors thank the Teaching Hospital, Peradeniya, for providing research facilities and encouragement. We thank our clinical investigators, Dr. K. S. Kularathne and Dr. I. B. Gawarammana, who provided samples and cared for study patients. Figure 7. Bland-Altman plots of methemoglobin concentration estimated by spectrophotometric and color chart methods. The difference is plotted against the Supervising editor: Richard C. Dart, MD, PhD average of the two methods. Differences from the gold Author contributions: FS wrote the first draft of the article, standard in future patient samples should lie between the performed all laboratory analyses, analyzed the data, had limits 95% of the time. access to all the data in the study, and had final responsibility for the decision to submit for publication. DMD and AHD concentration and thus allows treatment to be titrated against designed and set up the study. NAB contributed ideas to design the study. NAB and AHD provided statistical advice on response. In clinical use, the color chart shows a good agreement study design. All authors had a role in improving the study in Bland-Altman plot in spite of the aggregation of design and in reviewing and editing the final version of the methemoglobin concentrations in 5% (Figure 7). Because the article. FS takes responsibility for the paper as a whole. agreement between the color chart and the spectrophotometric method in actual clinical use was high, the color chart can be Funding and support: By Annals policy, all authors are required used clinically for the same purposes as a formal laboratory to disclose any and all commercial, financial, and other measurement. Changes of more than 10% from a previous relationships in any way related to the subject of this article reading are likely to represent a true change in methemoglobin that might create any potential conflict of interest. The authors have stated that no such relationships exist. See the concentration (Figure 7). Manuscript Submission Agreement in this issue for examples Our results show that variability in hemoglobin levels or of specific conflicts covered by this statement. This study was ambient light was not associated with significant variation in the supported by the South Asian Clinical Toxicology Research methemoglobin color value. It seemed that any change in color Collaboration, which is funded by The Wellcome perception affected both the chart and patient sample equally. Trust/National Health and Medical Research Council Because scanners use a consistent light source, we can also International Collaborative Research Grant GR071669MA. The assume that red, green, and blue values from scanned spots will funding bodies had no role in analyzing or interpreting the always be consistent for a given scanner. However, the color data or writing the article. value of the chart also depends on the printer inks and paper Publication dates: Received for publication March 30, 2009. and might fade with time. We recommend that printed versions Revision received June 9, 2009. Accepted for publication July of the color chart periodically be rescanned with a scanner and 22, 2009. Available online October 8, 2009. checked against the original red, green, and blue values shown in Figures 3 and 5. Reprints not available from the authors. Although there is a potential effect of methylene blue on the Address for correspondence: Fathima Shihana, BSc, South color of the blood sample, we did not observe any significant Asian Clinical Toxicology Research Collaboration, Faculty of effect 1 hour after administration. Even within an hour it is Medicine, University of Peradeniya, Sri Lanka; 94-081- likely that a relative change in methemoglobin with methylene 4479822, fax 94-081-4479822; E-mail shihana@sactrc.org. blue would still be detectable even if the actual estimates were less accurate. In any case, there is little clinical justification for taking repeated methemoglobin estimation within an hour of REFERENCES methylene blue administration. 1. Singh H, Purnell E, Smith C. Mechanistic study on aniline-induced erythrocyte toxicity. Arh Hig Rada Toksikol. 2007;58:275-285. Abnormal hemoglobins such as hemoglobin M may affect 2. Anderson CM, Woodside KJ, Spencer TA, et al. the color value because they are known to interfere with Methemoglobinemia: an unusual cause of postoperative cyanosis. estimates by co-oximetry.14 Similarly, some causes of J Vasc Surg. 2004;39:686-690. methemoglobin cause the formation of small amounts of 3. Camp NE. Methemoglobinemia. J Emerg Nurs. 2007;33:172-174. 188 Annals of Emergency Medicine Volume , .  : February 
  • 6. Shihana et al Bedside Test to Determine Methemoglobin 4. Fernando R. Managment of Poisoning. 3rd ed. Colombo, Sri 9. Watcha MF, Connor MT, Hing AV. Pulse oximetry in Lanka: National Poison Information Centre National Hospital of Sri methemoglobinemia. Am J Dis Child. 1989;143:845-847. Lanka; 2007. 10. Dacie J. Practical Haematology. 6th ed. New York, NY: Churchill 5. Cattaneo A, Furiosi D, Bolis C, et al. [Acute poisoning caused by Livingstone. 1984:148-149. methemoglobinemia-inducing substances. 6 cases]. Minerva Med. 11. Rasband W. ImageJ. v. 1.37. National Institutes of Health. Available at: 1987;78:1167-1176. http://rsbweb.nih.gov/ij/index.html.2006. Accessed August 19, 2009. 6. Eddleston M, Rajapakshe M, Roberts D, et al. Severe propanil 12. Harvey JW. Pathogenesis, laboratory diagnosis, and clinical [N-(3,4-dichlorophenyl) propanamide] pesticide self-poisoning. J implications of erythrocyte enzyme deficiencies in dogs, cats, and Toxicol Clin Toxicol. 2002;40:847-854. horses. Vet Clin Pathol. 2006;35:144-156. 7. De Silva WA, Bodinayake CK. Propanil poisoning. Ceylon Med J. 13. Chmura Kraemer H, Periyakoil VS, Noda A. Kappa coefficients in 1997;42:81-84. medical research. Stat Med. 2002;21:2109-2129. 8. Roberts DM, Heilmair R, Buckley NA, et al. Clinical outcomes and 14. Haymond S, Cariappa R, Eby CS, et al. Laboratory assessment kinetics of propanil following acute self-poisoning: a prospective of oxygenation in methemoglobinemia. Clin Chem. 2005;51: case series. BMC Clin Pharmacol. 2009;9:3. 434-444. Did you know? Annals accepts audio and video files as ancillaries to the main article. Visit http://www.annemergmed.com/content/instauth/ for more details! Volume , .  : February  Annals of Emergency Medicine 189